Evidence method
Level · gp.fundamentals.capex_revenue_ratio
7.64% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CRNX · Mar 31, 2026
Crinetics Pharmaceuticals, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001658247-26-000040General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1161.76% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
2873.41% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
28.54% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
98.14% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-1307.79% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
932.37% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
276.50% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History14 statesSelf-history eligible
Sep 30, 20190/6 normalizedLevel 3Dec 31, 20190/6 normalizedLevel 3Mar 31, 20200/6 normalizedLevel 3Dec 31, 20200/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20266/8 normalizedLevel 3Jun 30, 20266/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 74.87%
- Current
- 7.64%
- Delta
- -67.23%
- Previous
- -4910.63%
- Current
- -1161.76%
- Delta
- 3748.87%
- Previous
- 640.71%
- Current
- 2873.41%
- Delta
- 2232.70%
- Previous
- 26.27%
- Current
- 28.54%
- Delta
- 2.27%
- Previous
- 86.02%
- Current
- 98.14%
- Delta
- 12.12%
- Previous
- -6714.77%
- Current
- -1307.79%
- Delta
- 5406.99%
- Previous
- 4314.68%
- Current
- 932.37%
- Delta
- -3382.31%
- Previous
- 1182.74%
- Current
- 276.50%
- Delta
- -906.24%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Analogous To · CRNX state analogue 1 →Transitioned To · CRNX MARGIN_INCREASED →Transitioned To · CRNX PROFITABILITY_INCREASED →Transitioned To · CRNX R_AND_D_INTENSITY_DECREASED →Transitioned To · CRNX Fundamental State →Transitioned To · CRNX CAPEX_INTENSITY_DECREASED →Transitioned To · CRNX CASH_GENERATION_INCREASED →Transitioned To · CRNX GROWTH_INCREASED →Transitioned To · CRNX INVENTORY_PRESSURE_INCREASED →Transitioned To · CRNX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.